Monday, June 22, 2015 10:07:57 PM
He just bought 10,000 @ $.59/sh. $5900.00
In the last couple of years his totals sales are 463,333 shares. The price was driven up on franchise sales. He sold into that. That tells me something about what the CEO thought about the strength of those franchises.
Insider Trades of PAPPAS BRIAN Information
Click on the column header to resort ascending (?) or descending (?).
Individual Insider Trades
Company Relation Last Date ? Tran OwnerType Shares Traded Last Price Shares Held
CREATIVE LEARNING CORP Officer 07/23/2013 Disposition (Non Open Market) indirect 10,000 0.93 2,169,000
CREATIVE LEARNING CORP Officer 09/13/2013 Sell indirect 150,000 0.58 2,229,000
CREATIVE LEARNING CORP Officer 10/18/2013 Disposition (Non Open Market) indirect 33,333 1.75 2,135,667
CREATIVE LEARNING CORP Officer 11/03/2013 Disposition (Non Open Market) indirect 105,000 1.8 2,030,000
CREATIVE LEARNING CORP Officer 12/06/2013 Disposition (Non Open Market) indirect 15,000 1.82 2,015,667
CREATIVE LEARNING CORP Officer 03/18/2014 Disposition (Non Open Market) indirect 50,000 1.94 1,965,667
CREATIVE LEARNING CORP Officer 08/13/2014 Disposition (Non Open Market) indirect 50,000 2.2 1,915,667
CREATIVE LEARNING CORP Officer 09/16/2014 Disposition (Non Open Market) indirect 50,000 2.05 1,865,667
CREATIVE LEARNING CORP Officer 11/13/2014 Buy indirect 1,000 1.85 1,866,667
CREATIVE LEARNING CORP Officer 06/18/2015 Buy direct 10,000 0.59 1,875,667
Read more: http://www.nasdaq.com/quotes/insiders/pappas-brian#ixzz3dqY04NLS
Recent DWAY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/08/2024 03:21:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/08/2024 03:19:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 07:16:35 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/29/2023 11:03:33 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/30/2023 03:25:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM